Date/Time: March 27, 2018 - March 28, 2018, 8:00 am - 5:00 pm

The Biomarker Summit 2018 is a meeting place for leaders in the field to discuss the issues and challenges scientists and researchers face in all aspects of the biomarker and diagnostic development process from discovery to translation to commercialization.

Topics to be covered:

A wide variety of important topics will be covered including biomarker identification, validation, and translation strategies, bioinformatics and systems biology approaches to personalized medicine, big data analytics and management, regulatory and reimbursement trends, companion diagnostics development, and much more. Through scientific presentations, case studies and panel discussions, these areas will be addressed in an intimate and highly interactive environment with perspectives from industry, academia and the public sector.

Assembling leading scientists, researchers, decision-makers and other players across the industry spectrum, the Summit provides a unique opportunity to gain the latest biomarker developments in four major therapeutic areas, formally organized in the following tracks:

Joint Plenary Sessions

• Opening Keynote Session: Historical Perspective & Current State of the Industry
• Round Table Discussions
• Lunch Session: Big Data Analytics & Bioinformatics for Biomarkers Development
• Award Ceremony & Closing Keynote Session – Predictions for future

Oncology Biomarkers

• Immuno-Oncology Biomarkers
• Circulating Tumor Cells, Microvesicles, DNA and RNA

Neurological Biomarkers

• Biomarkers for Early Identification of Neurological Disease
• Monitoring Progression and Treatment Efficacy using Biomarkers

Inflammatory & Immunological Biomarkers

• Biomarkers for Early Progressive Inflammatory & Immunological Diseases
• Biomarkers as Surrogate Endpoints for Clinical Trials